LENZ Therapeutics Inc (LENZ)
15.29
-0.22
(-1.42%)
USD |
NASDAQ |
May 31, 16:00
15.30
+0.01
(+0.07%)
After-Hours: 20:00
LENZ Therapeutics Cash from Investing (Quarterly): 18.00M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 18.00M |
| September 30, 2023 | -44.79M |
| Date | Value |
|---|---|
| March 31, 2023 | -0.006M |
| September 30, 2022 | -0.034M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-44.79M
Minimum
Sep 2023
18.00M
Maximum
Mar 2024
-6.708M
Average
-0.02M
Median
Cash from Investing (Quarterly) Benchmarks
| TruBridge Inc | 16.39M |
| PetMed Express Inc | -1.423M |
| Streamline Health Solutions Inc | -0.012M |
| R1 RCM Inc | -698.40M |
| MoonLake Immunotherapeutics | -28.80M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.94M |
| Cash from Financing (Quarterly) | 171.27M |
| Free Cash Flow | -72.77M |
| Free Cash Flow Per Share (Quarterly) | -5.074 |
| Free Cash Flow Yield | -23.41% |